Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Anxo Río-Vilariño(Hospital Universitario Fundación Jiménez Díaz), Arancha Cebrián(Hospital Universitario Fundación Jiménez Díaz)

British Journal of Cancer

March 11, 2024

10.1038/s41416-024-02649-z

Cited by 18

Related Papers

No related papers found

Powered by citation graph analysis